Pomegranate sensitizes Tamoxifen action in ER-α positive breast cancer cells

Journal of Cell Communication and Signaling

Volumn 5, Issue 4, 2011, Pages 317-324

  Banerjee, Shreya ^a   Kambhampati, Suman ^a,b   Banerjee, Sushanta K ^a,b,c   Haque, Inamul ^a  

^a Molec Gastroenterol Pancreatic C   (United States)

^b UNIVERSITY OF KANSAS   (United States)

^c UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Estrogen receptor and breast cancer; Pomegranate; Tamoxifen

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR ALPHA; POMEGRANATE EXTRACT; TAMOXIFEN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CELL DEATH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DRUG POTENTIATION; DRUG RESPONSE; POMEGRANATE; PRIORITY JOURNAL;

LYTHRACEAE;

EID: 84856242855     PISSN: 18739601     EISSN: 1873961X     Source Type: Journal    
DOI: 10.1007/s12079-011-0138-y     Document Type: Article

References (31)

1. Ali S, Coombes RC (2000) Estrogen receptor alpha in human breast cancer: occurrence and significance. J Mammary Gland Biol Neoplasia 5:271-281 (Pubitemid 32156528)
2. Ali SH, O'Donnell AL, Balu D, Pohl MB, Seyler MJ, Mohamed S, Mousa S, Dandona P (2000) Estrogen receptor-alpha in the inhibition of cancer growth and angiogenesis. Cancer Res 60:7094-7098 (Pubitemid 32059189)
3. Banerjee SK, Campbell DR, Weston AP, Banerjee DK (1997) Biphasic estrogen response on bovine adrenal medulla capillary endothelial cell adhesion, proliferation and tube formation. Mol Cell Biochem 177:97-105 (Pubitemid 27522363)
4. Bartow SA (1999) The breast. In: Rubin E, Farber JL (eds) Pathology. Lippincott-Raven, Philadelphia, pp 1029-1048
5. Bell C, Hawthorne S (2008) Ellagic acid, pomegranate and prostate cancer - a mini review. J Pharm Pharmacol 60:139-144 (Pubitemid 351211828)
6. Christofori G (2006) New signals from the invasive front. Nature 441:444-450 (Pubitemid 44050139)
7. Crowe DR, Lampejo OT (1996) Malignant tumor of the breast. In: Blackwell RE, Grotting JC (eds) Diagnosis and management of breast cancer. England, Blackwell Sciences, pp 103-134
8. Dickson RB, Thompson EW, Lippman ME (1989) Hormones and breast cancer in vitro. Hum Cell 2:219-230
9. Hayes DF, Robertson JF (2002) Overview and concepts of endocrine therapy. In: Robertson JF, Nicholson RI, Hayes DF (eds) Endocrine therapy of breast cancer. Martin Dunitz Ltd, London, pp 3-10
10. Hilakivi-Clarke L, Cho E, Cabanes A, De Assis S, Olivo S, Helferich W, Lippman ME, Clarke R (2002) Dietary modulation of pregnancy estrogen levels and breast cancer risk among female rat offspring. Clin Cancer Res 8:3601-3610 (Pubitemid 35340739)
11. Hussain SA, Palmer DH, Spooner D, Rea DW (2007) Molecularly targeted therapeutics for breast cancer. BioDrugs 21:215-224 (Pubitemid 47104977)
12. Khan N, Afaq F, Kweon MH, Kim K, Mukhtar H (2007) Oral consumption of pomegranate fruit extract inhibits growth and progression of primary lung tumors in mice. Cancer Res 67:3475-3482 (Pubitemid 46724889)
13. Kumar R, Zhang H, Holm C, Vadlamudi RK, Landberg G, Rayala SK (2009) Extranuclear coactivator signaling confers insensitivity to tamoxifen. Clin Cancer Res 15:4123-4130
14. Mehta RG, Murillo G, Naithani R, Peng X (2010) Cancer chemoprevention by natural products: how far have we come? Pharm Res 27:950-961
15. Nayfield SG (1995) Tamoxifen's role in chemoprevention of breast cancer: an update. J Cell Biochem Suppl 22:42-50
16. Ormerod MG (2004) Cell-cycle analysis of asynchronous populations. Methods Mol Biol 263:345-54
17. Pantuck AJ, Leppert JT, Zomorodian N, Aronson W, Hong J, Barnard RJ, Seeram N, Liker H, Wang H, Elashoff R, Heber D, Aviram M, Ignarro L, Belldegrun A (2006a) Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer. Clin Cancer Res 12:4018-4026 (Pubitemid 44078089)
18. Pantuck AJ, Zomorodian N, Belldegrun as (2006b) Phase-II Study of pomegranate juice for men with prostate cancer and increasing PSA. Curr Urol Rep 7:7 (Pubitemid 44624024)
19. Pechoux C, Gudjonsson T, Ronnov-Jessen L, Bissell MJ, Petersen OW (1999) Human mammary luminal epithelial cells contain progenitors to myoepithelial cells. Dev Biol 206:88-99 (Pubitemid 29069876)
20. Rouzier R, Perou CM, Symmans WF, Ibrahim N, Cristofanilli M, Anderson K, Hess KR, Stec J, Ayers M, Wagner P, Morandi P, Fan C, Rabiul I, Ross JS, Hortobagyi GN, Pusztai L (2005) Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Clin Cancer Res 11:5678-5685 (Pubitemid 41170290)
21. Sengupta K, Banerjee S, Saxena NK, Banerjee SK (2004a) Thombospondin-1 disrupts estrogen-induced endothelial cell proliferation and migration and its expression is suppressed by estradiol. Mol Cancer Res 2:150-158 (Pubitemid 39030305)
22. Sengupta K, Banerjee S, Saxena NK, Jonathan NB, Campbell DR, Banerjee SK (2004b) Differential expression of VEGF-A mRNA by 17beta-estradiol in breast tumor cells lacking classical ER-alpha may be mediated through a variant form of ER-alpha. Mol Cell Biochem 262:215-224 (Pubitemid 39158071)
23. Sotiriou C, Neo SY, McShane LM, Korn EL, Long PM, Jazaeri A, Martiat P, Fox SB, Harris AL, Liu et (2003) Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci U S A 100:10393-10398 (Pubitemid 37071889)
24. Tavassoli FA (1999) Pathology of breast. McGraw-Hill, New York
25. Taylor IW, Hodson PJ, Green MD, Sutherland RL (1983) Effects of tamoxifen on cell cycle progression of synchronous MCF-7 human mammary carcinoma cells. Cancer Res 43:4007-4010 (Pubitemid 13041019)
26. Thompson EW, Katz D, Shima TB, Wakeling AE, Lippman ME, Dickson RB (1989a) ICI 164, 384, a pure antagonist of estrogenstimulated MCF-7 cell proliferation and invasiveness. Cancer Res 49:6929-6934 (Pubitemid 20016569)
27. Thompson EW, Martin MB, Saceda M, Clarke R, Brunner N, Lippman ME, Dickson RB (1989b) Regulation of breast cancer cells by hormones and growth factors: effects on proliferation and basement membrane invasiveness. Horm Res 32 (Suppl 1):242-249 (Pubitemid 20028588)
28. Toi M, Bando H, Ramachandran C, Melnick SJ, Imai A, Fife RS, Carr RE, Oikawa T, Lansky EP (2003) Preliminary studies on the antiangiogenic potential of pomegranate fractions in vitro and in vivo. Angiogenesis 6:121-128 (Pubitemid 38173863)
29. Tormey DC, Gray R, Falkson HC (1996) Postchemotherapy adjuvant tamoxifen therapy beyond five years in patients with lymph node-positive breast cancer. East Coop Oncol Group J Natl Cancer Inst 88:1828-1833 (Pubitemid 26425057)
30. Wang TT, Phang JM (1995) Effects of estrogen on apoptotic pathways in human breast cancer cell line MCF-7. Cancer Res 55:2487-2489
31. Zhang GJ, Kimijima I, Onda M, Kanno M, Sato H, Watanabe T, Tsuchiya A, Abe R, Takenoshita S (1999) Tamoxifen-induced apoptosis in breast cancer cells relates to down-regulation of bcl-2, but not bax and bcl-X (L), without alteration of p53 protein levels. Clin Cancer Res 5:2971-2977 (Pubitemid 29493977)